Prostate cancer

News

FDA clears AI-powered prostate cancer detection software

Software that can help pathologists detect prostate cancer from slides of biopsies more effectively has been approved by the FDA.

News

NICE changes its mind on J&J's Erleada in prostate cancer

NICE has reversed its position on Johnson & Johnson's oral prostate cancer therapy Erleada in patients with hormone-relapsed or hormone sensitive tumours, backing NHS use of the drug.

News

NICE's second Zytiga rejection 'shows need for flexible pric...

NICE has stuck with its original decision to reject NHS funding for Johnson & Johnson's Zytiga as a treatment for men with newly diagnosed advanced prostate cancer, drawing criticism fr

News

ASCO21: Novartis' prostate cancer radiotherapy extends survi...

Novartis' big investment in radiopharmaceuticals for cancer seems to have paid off, after lead candidate 177Lu-PSMA-617 helped men with advanced prostate cancer and few treatment options li

News

Bayer props up sagging radionuclide business with Noria acqu...

Bayer has agreed to buy Noria Therapeutics and its subsidiary PSMA Therapeutics, adding to its pipeline of radionuclide drugs for cancer as sales of its lead product in the category – Xofig

Events